120 related articles for article (PubMed ID: 37483523)
1. Corrigendum: Single and combined use of the platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and systemic immune-inflammation index in gastric cancer diagnosis.
Zhang J; Zhang L; Duan S; Li Z; Li G; Yu H
Front Oncol; 2023; 13():1200951. PubMed ID: 37483523
[TBL] [Abstract][Full Text] [Related]
2. Single and combined use of the platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and systemic immune-inflammation index in gastric cancer diagnosis.
Zhang J; Zhang L; Duan S; Li Z; Li G; Yu H
Front Oncol; 2023; 13():1143154. PubMed ID: 37064093
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer.
Polk N; Budai B; Hitre E; Patócs A; Mersich T
Pathol Oncol Res; 2022; 28():1610658. PubMed ID: 36277961
[TBL] [Abstract][Full Text] [Related]
4. Role of systemic immune-inflammatory index in early diagnosis of sepsis in newborns with CHD.
Aydogan S; Dilli D; Soysal C; Akduman H; Örün UA; Taşar M; Taşoglu I; Zenciroglu A
Cardiol Young; 2022 Nov; 32(11):1826-1832. PubMed ID: 35550698
[TBL] [Abstract][Full Text] [Related]
5. Correlations of preoperative systematic immuno-inflammatory index and prognostic nutrition index with a prognosis of patients after radical gastric cancer surgery.
Xu Z; Chen X; Yuan J; Wang C; An J; Ma X
Surgery; 2022 Jul; 172(1):150-159. PubMed ID: 35168816
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value and association of systemic inflammation for patients with stage IV gastric cancer.
Huang C; Li Z; Zhang Z; Xia X; Xu D; Zhao A; Zhao G
Acta Gastroenterol Belg; 2020; 83(2):255-263. PubMed ID: 32603044
[TBL] [Abstract][Full Text] [Related]
7. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
8. The correlation of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, derived neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with disease severity in recurrent aphthous stomatitis.
Tanacan E; Dinçer Rota D; Oktem R; Erdogan FG
J Cosmet Dermatol; 2022 Oct; 21(10):4858-4863. PubMed ID: 35150041
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Complete Blood Count, Venous Blood Gas Measurements, and Glucose/Potassium Ratio for Delayed Neuropsychiatric Syndrome in Children with Acute Carbon Monoxide Poisoning Due to Coal-Burning Stove.
Yalçın G; Tunca H; Sayınbatur B; Anıl M
Turk Arch Pediatr; 2023 May; 58(3):328-335. PubMed ID: 37144268
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study.
Lin J; Zhang W; Huang Y; Chen W; Wu R; Chen X; Lou N; Wang P
Cancer Manag Res; 2018; 10():4935-4944. PubMed ID: 30464594
[TBL] [Abstract][Full Text] [Related]
11. Systemic immune-inflammation index, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are predictors of sperm presence in microdissection testicular sperm extraction.
Bastug Y; Tokuc E; Bastug N; Artuk I; Tosun C; Cakiroglu HS; Aykan S
Andrologia; 2022 Jul; 54(6):e14419. PubMed ID: 35266170
[TBL] [Abstract][Full Text] [Related]
12. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio levels are associated with keratoconus.
Elbeyli A; Kurtul BE
Indian J Ophthalmol; 2021 Jul; 69(7):1725-1729. PubMed ID: 34146015
[TBL] [Abstract][Full Text] [Related]
13. The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer.
Song Q; Xu SX; Wu JZ; Ling L; Wang S; Shu XH; Ying DN; Pei WW; Wu YC; Sun SF; Zhang YN; Zhou SH; Shao ZY
Front Immunol; 2023; 14():1177403. PubMed ID: 37457691
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective magnesium sulfate administration increases maternal Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Systemic Immune-Inflammation Index.
Orgul G; Agbal T; Celen S; Caglar AT
Arch Gynecol Obstet; 2021 Jun; 303(6):1433-1437. PubMed ID: 33222038
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil/lymphocyte, platelet/lymphocyte, monocyte/lymphocyte ratios and systemic immune-inflammation index in patients with depression.
Zhu X; Li R; Zhu Y; Zhou J; Han X; Tong Y; Tan Y
Bratisl Lek Listy; 2023; 124(6):471-474. PubMed ID: 36876383
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Systemic Immune-inflammation Index and Mortality in Intensive Care Patients Diagnosed with Crimean-Congo Hemorrhagic Fever.
Gundogdu O; Avci O
J Coll Physicians Surg Pak; 2022 Dec; 32(12):1538-1543. PubMed ID: 36474371
[TBL] [Abstract][Full Text] [Related]
17. The role of inflammatory biomarkers in predicting primary acquired nasolacrimal duct obstruction and postoperative recurrence.
Garip R; Sakallıoğlu AK
Nagoya J Med Sci; 2023 May; 85(2):289-298. PubMed ID: 37346835
[TBL] [Abstract][Full Text] [Related]
18. Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer.
Hong X; Cui B; Wang M; Yang Z; Wang L; Xu Q
Tohoku J Exp Med; 2015 Aug; 236(4):297-304. PubMed ID: 26250537
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune-Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC).
Modica R; Minotta R; Liccardi A; Cannavale G; Benevento E; Colao A
J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373942
[TBL] [Abstract][Full Text] [Related]
20. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
